- Išsiųsime per 10–14 d.d.
/images/books/2820401/9780128185506.jpg)
- Autorius: Kristine E Shields
- Leidėjas: Academic Press
- ISBN-10: 0128185503
- ISBN-13: 9780128185506
- Formatas: 15.2 x 22.9 x 1.3 cm, minkšti viršeliai
- Kalba: Anglų
- Extra -15 % nuolaida šiai knygai su kodu: ENG15
Pregnancy and the Pharmaceutical Industry (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Aprašymas
Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities.
Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.
EXTRA 15 % nuolaida su kodu: ENG15
Akcija baigiasi už 5d.11:47:16
Nuolaidos kodas galioja perkant nuo 10 €. Nuolaidos nesumuojamos.
- Autorius: Kristine E Shields
- Leidėjas: Academic Press
- ISBN-10: 0128185503
- ISBN-13: 9780128185506
- Formatas: 15.2 x 22.9 x 1.3 cm, minkšti viršeliai
- Kalba: Anglų
Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities.
Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.
Atsiliepimai